Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Topotecan hydrochloride exhibits positive results in recurrent ovarian cancer patients

May 31, 1996

NSC-314622, a new topoisomerase I-targeted antitumor, described by NIH

May 31, 1996

Vinorelbine tartrate and cisplatin cocktail more effective than cisplatin alone

May 31, 1996

TAS-103, a dual inhibitor of DNA topoisomerase I and II

May 31, 1996

Rebeccamycin analogue undergoes phase I trial

May 31, 1996

Anthracycline antitumor agent FCE-23762 metabolites synthesized

May 31, 1996

M-246315: A new thymidylate synthase inhibitor

May 31, 1996

LL-95509 exhibits optimum activity against GARFT

May 31, 1996

Marimastat continues to show clinical efficacy

May 24, 1996

SU-101 interim results announced at ASCO

May 24, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...